Systematic Review

Published on 16 Mar 2023

Chemoprophylaxis for the prevention of tuberculosis in kidney transplant recipients: A systematic review and meta-analysis

in Renal Pharmacology

Zhihui Yuan
Sheng Chao
Yuan Xu
Yulin Niu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1022579

3,275 views
3 citations

Original Research

Published on 16 Mar 2023

Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2)

in Renal Pharmacology

Max Maane
Fangrui Xiu
Peter Bellstedt
Gerd A. Kullak-Ublick
Michele Visentin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1154213

2,021 views
1 citation

Review

Published on 15 Mar 2023

Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction

in Renal Pharmacology

Jiewu Huang
Ye Liang
Lili Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1142001

13,364 views
5 citations

Original Research

Published on 14 Mar 2023

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study

in Renal Pharmacology

Mian-Na Luo
Qingjun Pan
Ting Ye
Shangmei Li
Lawei Yang
Hua-Feng Liu
Yongzhi Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1093442

2,679 views

Review

Published on 09 Mar 2023

The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation

in Renal Pharmacology

Xingyu Gao
Haiying Zhang
Chang Zhang
Minghe Li
Xiao Yu
Yanan Sun
Yingai Shi
Hongxia Zhang
Xu He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1122065

2,059 views
4 citations

Original Research

Published on 07 Mar 2023

Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage

in Renal Pharmacology

Jianhua Zeng
Hao Huang
Yan Zhang
Xin Lv
Jiawei Cheng
Si Jue Zou
Yuanyuan Han
Songkai Wang
Li Gong
Zhangzhe Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1095487

5,697 views
7 citations

Original Research

Published on 27 Feb 2023

Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE/RAGE pathway: Network pharmacology and experimental validation

in Renal Pharmacology

Yipeng Fang
Yunfei Zhang
Chenxi Jia
Chunhong Ren
Xutao Zhao
Xin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1047184

3,742 views
3 citations

Correction

Published on 27 Feb 2023

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

in Renal Pharmacology

Xiaoshan Zhou
Haoran Dai
Hanxue Jiang
Hongliang Rui
Wenbin Liu
Zhaocheng Dong
Na Zhang
Qihan Zhao
Zhendong Feng
Yuehong Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1166591

1,294 views
1 citation

Original Research

Published on 24 Feb 2023

Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease

in Renal Pharmacology

Jackie Trink
Usman Ahmed
Kian O’Neil
Renzhong Li
Bo Gao
Joan C. Krepinsky

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098321

2,839 views
3 citations

Original Research

Published on 15 Feb 2023

YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway

in Renal Pharmacology

Xin Li
Tian-Kui Ma
Min Wang
Xiao-Dan Zhang
Tian-Yan Liu
Yue Liu
Zhao-Hui Huang
Yong-Hong Zhu
Shuang Zhang
Li Yin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1069348

4,380 views
4 citations

Review

Published on 15 Feb 2023

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases

in Renal Pharmacology

Qi Jin
Tongtong Liu
Danqian Chen
Liping Yang
Huimin Mao
Fang Ma
Yuyang Wang
Ping Li
Yongli Zhan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1097206

8,068 views
9 citations

Review

Published on 13 Feb 2023

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

in Renal Pharmacology

Saeed Alshahrani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101068

11,791 views
9 citations

Review

Published on 09 Feb 2023

How to use COVID-19 antiviral drugs in patients with chronic kidney disease

in Renal Pharmacology

Ajinath Kale
Vishwadeep Shelke
Neha Dagar
Hans-Joachim Anders
Anil Bhanudas Gaikwad

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1053814

24,570 views
15 citations

Editorial

Published on 07 Feb 2023

Editorial: Model organisms in renal pharmacology: 2022

in Renal Pharmacology

Ayman M. Mahmoud
Weiqiang Lin
Vikram Patial
Rajesh Nachiappa Ganesh
Pragasam Viswanathan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139806

1,042 views

Original Research

Published on 06 Feb 2023

Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury

in Renal Pharmacology

Jiahui Liu
Zhongtang Li
Yunlan Lao
Xiaoming Jin
Yuzhi Wang
Beibei Jiang
Riming He
Shudong Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1060464

5,858 views
3 citations

Review

Published on 06 Feb 2023

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism

in Renal Pharmacology

Ya-Fei Liu
Huan-Huan Wang
Yin-Hong Geng
Liang Han
Sheng-Hao Tu
Hui Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1112088

8,780 views
4 citations

Navigation group

Articles

Chemoprophylaxis for the prevention of tuberculosis in kidney transplant recipients: A systematic review and meta-analysis

Characterization of ligand-induced thermal stability of the human organic cation transporter 2 (OCT2)

Natural products for kidney disease treatment: Focus on targeting mitochondrial dysfunction

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study

The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation

Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage

Niaoduqing alleviates podocyte injury in high glucose model via regulating multiple targets and AGE/RAGE pathway: Network pharmacology and experimental validation

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy

Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease

YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway

Therapeutic potential of artemisinin and its derivatives in managing kidney diseases

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review

How to use COVID-19 antiviral drugs in patients with chronic kidney disease

Editorial: Model organisms in renal pharmacology: 2022

Network pharmacology, molecular docking, and experimental verification reveal the mechanism of San-Huang decoction in treating acute kidney injury

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism